Pharmafile Logo

Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body’s immune system to target and attack cancer.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Genesis Research Group

Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…

View Profile

Havas Life London

We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…

View Profile

Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…

View Profile

Springer Nature

Did you know that we publish over 3,000 journals, and that over 1,000 of those are clinical science journals? Promote your approved branded drugs and medical devices to our audience…

View Profile

Streaming Well

Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual stories and interactive experiences that connect with people.

View Profile

Uniphar

Uniphar Group is a trusted global partner to pharmaceutical, medtech, and supply chain and retail companies, working to improve patient access to medicines around the world.

View Profile

Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that we attend each year.

View Profile

Company Details

New Jersey Headquarters, 24 N. Main St, Pennington, NJ, 08534, USA
855.662.6732

 Latest Content from PMHub 

Advancing Human Health Through Precise Measures of Movement, Cognition, & Biometrics

Scott McMillan, CEO of XCO, discusses wearable technologies for chronic and acute disease monitoring, virtual trials, and assessment of athlete performance. Among other things, we also dive into the role...

Lucid Group opens our new space in Marlow

This week marks an important step for everyone here at Lucid Group, as we re-open our premises in the UK and US and evolve to a hybrid way of working....

Gamification for patient care, medical education, and virtual engagement

“Gamification”–adding game-like elements into non-game or real-world settings–has become a popular concept in the pharmaceutical, healthcare, and event industries. However, it is proving more than a mere buzzword. With diverse...

Understanding the role of provider collaboratives

Oli Hudson, Content Director at Wilmington Healthcare, takes a look at the new groups of providers that are expected to play a pivotal role in integrating care.

Research Partnership’s MedTech Division appoints two Directors

Press Releases | May 14, 2021 | Inizio

Chris Carles has joined as a Director in our Philadelphia office and Andrew Way as a Research Director in our UK office.

How to Simplify Genetics & Raise Awareness Around Orphan Diseases

Dr. Gail Ouellette, President and Scientific Director of Regroupement Québécois des Maladies Orphelines (RQMO)/Quebec Coalition of Orphan Diseases and Creator of the “Genetics Simply" website, shares her thoughts on the...

Exploring Digital Health From a Patient Perspective

Tjaša Zajc, MedsClub Community Developer and Communication Specialist at Better and the Founder & Host of the Faces of Digital Health podcast, explores international differences in the speed of digital...

FREE webinar: Is there a doctor in the house?

Join the discussion on the value of having a medical degree for a career in medical communications

The power of communication: Engaging diverse groups in healthcare

Humans are diverse and communications to engage us need to be inclusive. It’s no longer about talking to a group, a cohort or an imagined section of society - especially...